Healthcare provider profile · identity verified

Sandi Lynn Casey, APRN

Nurse Practitioner · TAHLEQUAH, OK · NPI 1356791891

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	372	85
Lisinopril	Lisinopril	353	98
Atorvastatin Calcium	Atorvastatin Calcium	332	86
Amlodipine Besylate	Amlodipine Besylate	324	91
Losartan Potassium	Losartan Potassium	314	88
Omeprazole	Omeprazole	275	70
Gabapentin	Gabapentin	253	66
Pantoprazole Sodium	Pantoprazole Sodium	208	59
Hydrochlorothiazide	Hydrochlorothiazide	206	46
Rosuvastatin Calcium	Rosuvastatin Calcium	206	52
Furosemide	Furosemide	181	44
Fluticasone Propionate	Fluticasone Propionate	178	54
Albuterol Sulfate Hfa	Albuterol Sulfate	165	54
Metformin Hcl	Metformin Hcl	158	45
Metoprolol Succinate	Metoprolol Succinate	157	39
Trazodone Hcl	Trazodone Hcl	144	33
Duloxetine Hcl	Duloxetine Hcl	127	39
Potassium Chloride	Potassium Chloride	119	34
Ondansetron Odt	Ondansetron	117	43
Metoprolol Tartrate	Metoprolol Tartrate	114	35
Meloxicam	Meloxicam	112	32
Topiramate	Topiramate	109	12
Ozempic	Semaglutide	108	25
Eliquis	Apixaban	103	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	102	36
Glipizide	Glipizide	97	33
Tamsulosin Hcl	Tamsulosin Hcl	97	27
Famotidine	Famotidine	94	28
Jardiance	Empagliflozin	94	20
Sertraline Hcl	Sertraline Hcl	94	17
Carvedilol	Carvedilol	92	25
Montelukast Sodium	Montelukast Sodium	92	28
Prednisone	Prednisone	91	64
Ropinirole Hcl	Ropinirole Hcl	88	24
Clopidogrel	Clopidogrel Bisulfate	80	27
Escitalopram Oxalate	Escitalopram Oxalate	77	17
Simvastatin	Simvastatin	77	16
Hydroxyzine Hcl	Hydroxyzine Hcl	75	31
Fluconazole	Fluconazole	74	48
Pravastatin Sodium	Pravastatin Sodium	73	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	72	14
Baclofen	Baclofen	71	20
Sucralfate	Sucralfate	68	12
Buspirone Hcl	Buspirone Hcl	67	25
Fluoxetine Hcl	Fluoxetine Hcl	66	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	14
Celecoxib	Celecoxib	65	20
Spironolactone	Spironolactone	59	14
Pioglitazone Hcl	Pioglitazone Hcl	58	suppressed
Tizanidine Hcl	Tizanidine Hcl	57	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	12
Propranolol Hcl	Propranolol Hcl	53	14
Mupirocin	Mupirocin	51	34
Alendronate Sodium	Alendronate Sodium	50	13
Citalopram Hbr	Citalopram Hydrobromide	49	14
Amitriptyline Hcl	Amitriptyline Hcl	48	12
Mirtazapine	Mirtazapine	48	13
Hydralazine Hcl	Hydralazine Hcl	46	11
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Atenolol	Atenolol	42	suppressed
Metformin Hcl Er	Metformin Hcl	42	13
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Clonidine Hcl	Clonidine Hcl	41	suppressed
Memantine Hcl	Memantine Hcl	41	11
Nabumetone	Nabumetone	41	15
Lamotrigine	Lamotrigine	40	suppressed
Tramadol Hcl	Tramadol Hcl	39	13
Pregabalin	Pregabalin	36	suppressed
Allopurinol	Allopurinol	35	suppressed
Azithromycin	Azithromycin	35	31
Bupropion Xl	Bupropion Hcl	35	suppressed
Ibuprofen	Ibuprofen	34	21
Lorazepam	Lorazepam	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Finasteride	Finasteride	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Cefdinir	Cefdinir	25	23
Hydrocortisone	Hydrocortisone	25	suppressed
Olanzapine	Olanzapine	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Naproxen	Naproxen	22	11
Phenobarbital	Phenobarbital	22	suppressed
Sulindac	Sulindac	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Linzess	Linaclotide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	18
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Letrozole	Letrozole	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Torsemide	Torsemide	19	suppressed
Valsartan	Valsartan	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Nystatin	Nystatin	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Indapamide	Indapamide	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Scopolamine	Scopolamine	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Methimazole	Methimazole	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Pulmicort Flexhaler	Budesonide	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Cephalexin	Cephalexin	11	11
Constulose	Lactulose	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error